BRAND NAME:
Bilinta

GENERIC NAME:
Ticagrelor

THERAPEUTIC SEGMENT:
Platelet aggregation inhibitor

INDICATIONS:
BILINTA is indicated to reduce the rate of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. For at least the first 12 months following ACS, it is superior to clopidogrel.


BILINTA also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS.

BRIEF DESCRIPTION:
Ticagrelor is a platelet aggregation inhibitor works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It keeps blood flowing smoothly in your body. Ticagrelor is used along with low-dose aspirin to help prevent heart attack and stroke in people with heart problems (such as unstable angina, previous heart attack). It may also be used to prevent heart attack or stroke after certain heart surgeries (such as stent placement, coronary artery bypass graft-CABG, or angioplasty).

DOSAGE FORM:
Tablets

PACK SIZE:
20's